-
Mashup Score: 1Late-breaking clinical trials at TCT 2023 - 6 month(s) ago
Here is a list of all the late-breaking clinical trials being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 annual meeting Oct. 23-26, 2023, in San Francisco.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound - 6 month(s) ago
October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for use in atrial transseptal procedures and delivery of catheters, has now been successfully used in 15 human cases, at major cardiology hospitals in Arizona and Minnesota. UltraNav improves the safety and accuracy of transseptal procedures by enabling better visualization of the catheter, needle, and needle tip. It facilitates safer and more predictable transport of intracardiac echocardiography (ICE) and other catheters/wires from the right into the left atrium of the heart. Its use also suggests it may reduce the need for Transesophageal Echo (TEE) interventions. UltraNav replaces the current procedural approach of using a separate needle and ultrasound beam on two different planes, which provides only a partial image of the orientation and depth of the needle and its tip, further disrupted by the cardiac and respirator
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
What are the latest updates on treating tricuspid regurgitation? We spoke with a leading researcher at ESC Congress 2023 to find out.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2The American Association for Thoracic Surgery | AATS | 104th Annual… - 8 month(s) ago
The AATS welcomes you to submit your abstracts and case videos to the 104th Annual Meeting. Selected abstracts and videos will be presented in-person April 27-30, 2024 in Toronto. Waiver of mandatory manuscript submission for publication in JTCVS may be requested at the time of submission. The requirement for manuscript submission to the JTCVS does not apply to Abstracts for the C. Walton Lillehei Resident Forum, posters, or case videos. Click on a category for more information. Clinical and translational
Source: events.aats.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Interventional echocardiography expected to grow thanks to new structural heart procedures - 8 month(s) ago
American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Interventional echocardiographers play a key role in the treatment of structural heart disease - 8 month(s) ago
Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Capstan Medical Raises 31.4M in Funding - 9 month(s) ago
Capstan Medical, a Santa Cruz, CA-based developer of minimally invasive technology to address heart valve disease, raised $31.4m in Series B funding
Source: www.finsmes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The first patient was enrolled in a multicenter clinical trial for the TaurusTrio transcatheter aortic valve replacement system, used for aortic regurgitation.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Abbott is pulling its Trifecta valves off the market - 9 month(s) ago
The Trifecta withdrawal comes more than five months after Abbott and the FDA told health providers that the valves could deteriorate early.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet
Here is a list of all the late-breaking clinical trials being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 annual meeting #Cardiotwitter #cardiology #PCI #Cathlab #structuralheart #TCT #TCT2023 https://t.co/QEsVdDlqU4